Research ArticleNeurology
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, Michel Koole, Bala Attili, Sofie Celen, Lieven Declercq, Dietmar R. Thal, Philip Van Damme, Guy Bormans and Koen Van Laere
Journal of Nuclear Medicine April 2020, 61 (4) 604-607; DOI: https://doi.org/10.2967/jnumed.119.231985
Donatienne Van Weehaeghe
1Division of Nuclear Medicine, Department of Imaging and Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
Evelien Van Schoor
2Department of Neurology, University Hospitals Leuven, and Laboratory of Neurobiology, Center for Brain and Disease Research, VIB, KU Leuven, Leuven, Belgium
3Leuven Brain Institute, KU Leuven, Leuven, Belgium
4Laboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
Joke De Vocht
2Department of Neurology, University Hospitals Leuven, and Laboratory of Neurobiology, Center for Brain and Disease Research, VIB, KU Leuven, Leuven, Belgium
Michel Koole
1Division of Nuclear Medicine, Department of Imaging and Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
Bala Attili
5Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; and
Sofie Celen
5Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; and
Lieven Declercq
5Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; and
Dietmar R. Thal
3Leuven Brain Institute, KU Leuven, Leuven, Belgium
4Laboratory for Neuropathology, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium
6Department of Pathology, UZ Leuven, Leuven, Belgium
Philip Van Damme
2Department of Neurology, University Hospitals Leuven, and Laboratory of Neurobiology, Center for Brain and Disease Research, VIB, KU Leuven, Leuven, Belgium
Guy Bormans
5Laboratory for Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium; and
Koen Van Laere
1Division of Nuclear Medicine, Department of Imaging and Pathology, University Hospitals Leuven, KU Leuven, Leuven, Belgium
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 4
April 1, 2020
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, Michel Koole, Bala Attili, Sofie Celen, Lieven Declercq, Dietmar R. Thal, Philip Van Damme, Guy Bormans, Koen Van Laere
Journal of Nuclear Medicine Apr 2020, 61 (4) 604-607; DOI: 10.2967/jnumed.119.231985
TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study
Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht, Michel Koole, Bala Attili, Sofie Celen, Lieven Declercq, Dietmar R. Thal, Philip Van Damme, Guy Bormans, Koen Van Laere
Journal of Nuclear Medicine Apr 2020, 61 (4) 604-607; DOI: 10.2967/jnumed.119.231985
Jump to section
Related Articles
Cited By...
- Different patterns of structural network impairments in two amyotrophic lateral sclerosis subtypes driven by 18F-FDG PET/MR hybrid imaging
- Imaging Neuroinflammation in Neurodegenerative Disorders
- Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
- Neuroinflammation PET Imaging: Current Opinion and Future Directions